These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 32176632)
21. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer. Wang J; Zhao S; Wang F; Wang J; Zhang Y Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray. Wang S; Yin C; Zhang Y; Zhang L; Tao L; Liang W; Pang L; Fu R; Ding Y; Li F; Jia W Biomed Res Int; 2019; 2019():2867372. PubMed ID: 31312656 [TBL] [Abstract][Full Text] [Related]
23. SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis. Yang M; Xie X; Ding Y Oncol Rep; 2016 Mar; 35(3):1796-806. PubMed ID: 26750614 [TBL] [Abstract][Full Text] [Related]
24. WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study. Netinatsunthorn W; Hanprasertpong J; Dechsukhum C; Leetanaporn R; Geater A BMC Cancer; 2006 Apr; 6():90. PubMed ID: 16606472 [TBL] [Abstract][Full Text] [Related]
25. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer. Ma M; Yu N Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213 [TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma. Unger U; Denkert C; Braicu I; Sehouli J; Dietel M; Loibl S; Darb-Esfahani S Virchows Arch; 2017 Feb; 470(2):143-151. PubMed ID: 27913862 [TBL] [Abstract][Full Text] [Related]
27. [Expression of THY1 gene in epithelial ovarian cancer]. Zeng LQ; Peng ZL; Duan ZL Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):118-20. PubMed ID: 19538887 [TBL] [Abstract][Full Text] [Related]
28. The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer. King ER; Tung CS; Tsang YT; Zu Z; Lok GT; Deavers MT; Malpica A; Wolf JK; Lu KH; Birrer MJ; Mok SC; Gershenson DM; Wong KK Am J Surg Pathol; 2011 Jun; 35(6):904-12. PubMed ID: 21451362 [TBL] [Abstract][Full Text] [Related]
29. Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer. Hooda J; Novak M; Salomon MP; Matsuba C; Ramos RI; MacDuffie E; Song M; Hirsch MS; Lester J; Parkash V; Karlan BY; Oren M; Hoon DS; Drapkin R Cancer Res; 2019 Feb; 79(4):760-772. PubMed ID: 30563893 [TBL] [Abstract][Full Text] [Related]
30. High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer. Sopo M; Sallinen H; Hämäläinen K; Kivelä A; Ylä-Herttuala S; Kosma VM; Keski-Nisula L; Anttila M PLoS One; 2020; 15(11):e0241484. PubMed ID: 33151982 [TBL] [Abstract][Full Text] [Related]
31. Overexpression of multiple myeloma SET domain (MMSET) is associated with advanced tumor aggressiveness and poor prognosis in serous ovarian carcinoma. Yang S; Zhang Y; Meng F; Liu Y; Xia B; Xiao M; Xu Y; Ning X; Li H; Lou G Biomarkers; 2013 May; 18(3):257-63. PubMed ID: 23566000 [TBL] [Abstract][Full Text] [Related]
32. Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma. Nymoen DA; Hetland Falkenthal TE; Holth A; Ow GS; Ivshina AV; Tropé CG; Kuznetsov VA; Staff AC; Davidson B Gynecol Oncol; 2015 Oct; 139(1):30-9. PubMed ID: 26232338 [TBL] [Abstract][Full Text] [Related]
33. Nuclear G protein-coupled oestrogen receptor (GPR30) predicts poor survival in patients with ovarian cancer. Zhu CX; Xiong W; Wang ML; Yang J; Shi HJ; Chen HQ; Niu G J Int Med Res; 2018 Feb; 46(2):723-731. PubMed ID: 29239277 [TBL] [Abstract][Full Text] [Related]
34. [Expression and clinicopathologic significance of CD44v6/CD24 in ovarian serous carcinomas]. Wang A; Lu L; Wang Y; Sun Y; Zhang Y; Guo C; Gu Y; Liu A Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):20-4. PubMed ID: 24713244 [TBL] [Abstract][Full Text] [Related]
35. MYH9 overexpression correlates with clinicopathological parameters and poor prognosis of epithelial ovarian cancer. Liu L; Yi J; Deng X; Yuan J; Zhou B; Lin Z; Zeng Z Oncol Lett; 2019 Aug; 18(2):1049-1056. PubMed ID: 31423165 [TBL] [Abstract][Full Text] [Related]
36. Expression of Interactive Genes Associated with Apoptosis and Their Prognostic Value for Ovarian Serous Adenocarcinoma. Shin K; Kim KH; Yoon MS; Suh DS; Lee JY; Kim A; Eo W Adv Clin Exp Med; 2016; 25(3):513-21. PubMed ID: 27629740 [TBL] [Abstract][Full Text] [Related]
37. Expression of Placenta Growth Factor Is Associated with Unfavorable Prognosis of Advanced-Stage Serous Ovarian Cancer. Meng Q; Duan P; Li L; Miao Y Tohoku J Exp Med; 2018 Apr; 244(4):291-296. PubMed ID: 29643276 [TBL] [Abstract][Full Text] [Related]
38. [Expressions and clinical significances of paired box gene 2 and cyclin D1 in advanced ovarian serous carcinoma]. Song Y; Zuo J; Huang X; Shen GH; Liu XY; Zhang X Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):891-895. PubMed ID: 29262504 [No Abstract] [Full Text] [Related]
39. LGR4 maintains HGSOC cell epithelial phenotype and stem-like traits. Wang Z; Yin P; Sun Y; Na L; Gao J; Wang W; Zhao C Gynecol Oncol; 2020 Dec; 159(3):839-849. PubMed ID: 32980127 [TBL] [Abstract][Full Text] [Related]
40. The potential prognostic value of cathepsin D protein in serous ovarian cancer. Chai Y; Wu W; Zhou C; Zhou J Arch Gynecol Obstet; 2012 Aug; 286(2):465-71. PubMed ID: 22476353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]